Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Episode 9 September 01, 2021 00:47:27
Episode 9:  Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Sep 01 2021 | 00:47:27

/

Show Notes

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael Graglia from SynGAP Research Fund, discussing the importance of diagnosing #raredisease early and the critical step of sharing study data.

Other Episodes

Episode 28

February 23, 2023 00:30:48
Episode Cover

Episode 28: Dr. Alok Tayi, Founder and CEO of VibeBio

“I think one of the key insights and observations you make when you have a child who's sick and you spend time with other...

Listen

Episode 17

January 12, 2022 00:39:58
Episode Cover

Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s...

Listen

Episode 51

April 03, 2025 00:55:05
Episode Cover

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

How do you turn back the epigenetic clock for humans and their animal companions?  Host Chris O'Brien welcomes Dan Oliver, CEO and Founder of...

Listen